NEO
NEOGENOMICS INC
+0.85 (+4.49%)19.79USD592K成交股數2.5B市值–本益比(近四季)3.3股價營收比+11.2%營收年增(近四季)2026-10-27下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 202M+11% | 187M+11% | 190M+13% | 188M+14% | 181M+16% | 168M+8% | 168M+10% | 165M+12% | 156M | 156M | 152M | 147M |
| 營業成本 | 110M | 106M | 107M | 107M | 104M | 94.8M | 92.9M | 92.0M | 90.8M | 88.0M | 89.6M | 87.0M |
| 毛利 | 91.9M+19% | 80.9M+10% | 83.3M+11% | 80.4M+11% | 77.3M+18% | 73.2M+8% | 74.9M+20% | 72.5M+21% | 65.5M | 67.6M | 62.3M | 59.9M |
| 毛利率 | 45.6% | 43.3% | 43.8% | 42.8% | 42.6% | 43.6% | 44.6% | 44.1% | 41.9% | 43.5% | 41.0% | 40.8% |
| 研發費用 | 10.8M | 9.5M | 9.2M | 8.7M | 9.0M | 10.2M | 7.7M | 7.9M | 7.6M | 7.1M | 5.3M | 7.5M |
| 銷售管理費用 | 63.6M | 65.7M | 63.5M | 69.9M | 71.7M | 68.2M | 67.0M | 63.3M | 65.8M | 59.8M | 61.5M | 60.3M |
| 營業利益 | −9.8M-79% | −18.2M-34% | −13.4M-37% | −27.0M+23% | −47.6M+56% | −27.8M+50% | −21.2M-12% | −21.9M-27% | −30.6M | −18.6M | −24.2M | −29.9M |
| 營業利益率 | -4.8% | -9.8% | -7.1% | -14.4% | -26.3% | -16.6% | -12.6% | -13.3% | -19.6% | -11.9% | -15.9% | -20.3% |
| 稅後淨利 | 2.2M-105% | −17.1M-34% | −9.9M-44% | −27.1M+46% | −45.1M+67% | −25.9M+81% | −17.7M-4% | −18.6M-23% | −27.1M | −14.4M | −18.5M | −24.3M |
| 淨利率 | 1.1% | -9.2% | -5.2% | -14.4% | -24.9% | -15.4% | -10.5% | -11.3% | -17.3% | -9.2% | -12.2% | -16.6% |
| 稀釋 EPS | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋股數 | 131M | 129M | 128M | 128M | 128M | 127M | 127M | 126M | 126M | 126M | 126M | 125M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 146M | 146M | 160M | 164M | 155M | 346M | 362M | 355M | 332M | 342M | 306M | 289M |
| 應收帳款 | 175M | 167M | 159M | 155M | 153M | 151M | 151M | 147M | 140M | 131M | 133M | 125M |
| 存貨 | 27.1M | 29.8M | 28.6M | 28.5M | 34.2M | 29.8M | 24.5M | 23.2M | 20.3M | 24.2M | 24.1M | 24.9M |
| 總資產 | 1.4B | 1.3B | 1.4B | 1.4B | 1.4B | 1.6B | 1.6B | 1.6B | 1.6B | 1.7B | 1.7B | 1.7B |
| 有息負債 | 374M | – | 342M | – | – | – | – | – | – | 538M | – | – |
| 總負債 | 567M | 518M | 523M | 536M | 540M | 713M | 733M | 727M | 717M | 740M | 731M | 739M |
| 股東權益 | 786M | 829M | 837M | 838M | 854M | 888M | 908M | 916M | 923M | 942M | 947M | 956M |
| 負債比 | 41.9% | 38.5% | 38.5% | 39.0% | 38.7% | 44.5% | 44.7% | 44.3% | 43.7% | 44.0% | 43.5% | 43.6% |
| 淨現金(現金 − 有息負債) | −229M | – | −182M | – | – | – | – | – | – | −196M | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −8.1M-68% | – | – | – | −25.3M | – | – | −25.9M | – | – | – |
| 資本支出 | – | 5.0M | – | – | – | 4.5M | – | – | 5.6M | – | – | – |
| 自由現金流 | – | −13.1M-56% | – | – | – | −29.8M | – | – | −31.5M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -7.0% | – | – | – | -17.8% | – | – | -20.2% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 727M
| Reportable | 727M | 100.0% | +10.1% |
|---|
產品／服務2025 年度 · 727M
| Client Direct Billing | 519M | 71.3% | +9.1% |
|---|---|---|---|
| Commercial Insurance | 118M | 16.2% | +17.7% |
| Medicare And Other Governmental | 90.9M | 12.5% | +7.4% |
| Self Pay Services | 114K | 0.0% | -83.3% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 727M | +10.1% | −108M | -14.8% | – | −21.8M |
| FY2024 | 661M | +11.6% | −79.0M | -12.0% | – | −34.0M |
| FY2023 | 592M | +16.1% | −88.0M | -14.9% | – | −30.7M |
| FY2022 | 510M | +5.2% | −144M | -28.3% | – | −96.9M |
| FY2021 | 484M | +9.0% | −8.0M | -1.7% | – | −90.9M |
| FY2020 | 444M | +8.7% | 4.2M | 0.9% | – | −27.6M |
| FY2019 | 409M | +47.7% | 8.0M | 2.0% | – | 3.3M |
| FY2018 | 277M | – | 2.6M | 1.0% | – | 30.5M |